Actively Recruiting
Use of Ctdna in Patients With Gastrointestinal Tract Tumors
Led by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Updated on 2025-09-02
100
Participants Needed
1
Research Sites
261 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study will evaluate the use of ctDNA in the clinical management of patients with tumors of the gastrointestinal tract.
CONDITIONS
Official Title
Use of Ctdna in Patients With Gastrointestinal Tract Tumors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age >18 years
- Performance status ECOG less than 2
- Histological diagnosis of gastrointestinal cancer including esophageal, gastric, intestinal, pancreatic, or biliary tract tumors
- Radiological evidence of resectable, locally advanced, or metastatic disease at the time of consent
- Adequate organ function
- Availability of tumor histological material
You will not qualify if you...
- No histological diagnosis of gastrointestinal tract cancer
- No written informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Policlinico Agostino Gemelli
Rome, Lazio, Italy, 00168
Actively Recruiting
Research Team
L
Lisa Salvatore, MD, PhD
CONTACT
G
Giovanni Trovato, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here